Latest news
$400B AstraZeneca-Bristol Myers Squibb merger rumor draws market reaction - AxiosAxios · Fri, 07 Aug 2026 21:39:29 GMTAstraZeneca, BMS not pursuing merger talks: Reuters - NJBIZNJBIZ · Thu, 06 Aug 2026 17:42:22 GMTBristol Myers (BMY) Moves to Buy: Rationale Behind the Upgrade - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 16:00:02 GMTBristol-Myers Squibb suffers another EPO Opdivo patent loss - IAM PatentIAM Patent · Thu, 06 Aug 2026 13:32:21 GMTAstraZeneca may buck a decade of pharma strategy to buy U.S. scale - CNBCCNBC · Thu, 06 Aug 2026 09:40:16 GMTFamily experience inspires mental health advocacy - Bristol Myers SquibbBristol Myers Squibb · Thu, 06 Aug 2026 07:00:00 GMTSource Denies AstraZeneca-Bristol Myers Merger Talks | PharmExec - Pharmaceutical ExecutivePharmaceutical Executive · Wed, 05 Aug 2026 19:02:42 GMTBeyond the Megamerger: How Rumored AstraZeneca–BMS Discussions Signal a New Era of Pharmaceutical Competition - Pharmaceutical ExecutivePharmaceutical Executive · Wed, 05 Aug 2026 15:17:36 GMT